In conclusion, this study first elucidates the oncogenic role of hypomethylation- and hypermethylation-mediated regulation of CYSLTR1 and CYSLTR2 expression in CRC, respectively. The gene discussed is CYSLTR1; the disease is colorectal carcinoma.